Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact


Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo in 1993 as a first generation internet teaching tool consolidating human embryology teaching for first year medical students.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human.

The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.


WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!



Home

History

Bibliography

Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

April 3, 2013--------News Archive Return to: News Alerts


Researchers led by academics at The University of Nottingham, found that being
obese, suffering bleeding during pregnancy or labour and having a premature birth or
delivery via caesarean section, increased the risk of a venous thromboembolism (VTE).







WHO Child Growth Charts

       

Risks of blood clots in pregnant/postnatal women?

Women who have suffered a still birth or have medical conditions including varicose veins, inflammatory bowel disease (IBD) or heart disease are at greater risk of developing dangerous blood clots after giving birth, a study has revealed.

The research, led by academics at The University of Nottingham, found that being obese, suffering bleeding during pregnancy or labour and having a premature birth or delivery via caesarean section also increased the risk of a venous thromboembolism (VTE).

Their findings, published in the American Society of Hematology journal Blood, could have important implications for the way in which at-risk women are identified and preventative measures administered.

Epidemiologist Dr Matthew Grainge, in the University’s School of Community Health Sciences, who led the study, said: “VTE is a rare but serious complication of pregnancy and childbirth. It affects around one or two pregnancies per 1,000 but, despite this, remains a leading cause of mortality in expectant and new mothers in developed countries.


“Preventative measures for VTE, such as a daily dose of
heparin, may not be cost effective or safe and are therefore
only recommended for women who are considered high risk.

However, there is currently inconsistency and disagreement
over the factors which put women in that high-risk category
and we hope that this research will provide clinicians
with valuable new information.”

Dr Matthew Grainge
School of Community Health Sciences
University of Nottingham


Life-threatening

VTE — such as deep vein thrombosis (DVT) — are blood clots that form in a blood vessel and can be potentially life-threatening if the clot breaks off (embolises) and travels to the lung causing a blockage of the arteries of the lung known as pulmonary embolism (PE).

The study used data from GP patient records, hospital discharge forms and medications prescribed by primary healthcare professionals to study pregnancies of women aged between 15 and 44 between January 1995 and July 2009 — totalling almost 400,000 pregnancies.

Researchers identified all women who developed VTE for the first time during their pregnancy, including deep vein thrombosis (DVT), then extracted important key information about the mother from their medical records including their age, body mass index (BMI) and whether they smoked.

Calculating the risks

In addition, they considered other pregnancy-related factors such as how the baby was delivered, whether it was a stillbirth or premature birth and any associated complications including pre-eclampsia, diabetes and high blood pressure.


Co-existing medical factors including varicose veins,
inflammatory bowel disease (IBD) and heart conditions
such as heart disease were also taken into account.


They then used sophisticated data analysis methods to calculate the incident rate ratios to compare the risks of VTE to people without the specified risk factor.

They discovered that the risk of VTE during pregnancy was only marginally higher for women who were aged over 35 years old, had a BMI greater than 25 or who smoked. Medical complications such as pre-existing diabetes, varicose veins and IBD were all associated with greater risk, but not pre-existing high blood pressure.

Stillbirth 'most significant risk'


The risks were much higher for new mothers.

Postnatal women with a BMI greater than 30 were four times
more likely to develop a VTE, while delivery by caesarean
section, multiple previous births (three or more),
bleeding in pregnancy and premature birth all
doubled the chances of a women developing a VTE.

Perhaps most significantly, women who suffered a still birth
were six times more likely to have a VTE.


Dr Grainge added: “Our results may have important implications for the way that preventative measures for VTE are delivered in healthcare settings in developed countries. We believe the strong association between stillbirths and premature births and VTE in particular is a finding of real importance which has received only limited attention to date. They are not currently incorporated in the guidelines for risk assessment for VTE and, if they were, then many cases associated with those risk factors could potentially be prevented.”

The study, Risk Factors for First Venous Thromboembolism Around Pregnancy: A Population Based Cohort Study from the United Kingdom, was carried out as part of a PhD project on VTE prevention by Alyshah Abdul Sultan in collaboration with Professor Catherine Nelson-Piercy at the Women’s Health Academic Centre at Guy’s and St Thomas’ Foundation Trust.

The University of Nottinghamhas 42,000 students at award-winning campuses in the United Kingdom, China and Malaysia. It was ‘one of the first to embrace a truly international approach to higher education’, according to the Sunday Times University Guide 2013. It is also one of the most popular universities among graduate employers, one of the world’s greenest universities, and winner of the Times Higher Education Award for ‘Outstanding Contribution to Sustainable Development’. It is ranked in the UK's Top 10 and the World's Top 75 universities by the Shanghai Jiao Tong and the QS World Rankings.

More than 90 per cent of research at The University of Nottingham is of international quality, according to the most recent Research Assessment Exercise. The University aims to be recognised around the world for its signature contributions, especially in global food security, energy & sustainability, and health. The University won a Queen’s Anniversary Prize for Higher and Further Education for its research into global food security.

Impact: The Nottingham Campaign, its biggest ever fundraising campaign, will deliver the University’s vision to change lives, tackle global issues and shape the future. More news…

Original article: http://www.nottingham.ac.uk/news/pressreleases/2013/april/study-reveals-risk-factors-for-blood-clots-in-pregnant-and-postnatal-women.aspx